407 related articles for article (PubMed ID: 31842789)
1. Granulocyte-colony stimulating factor-associated aortitis in a woman with advanced breast cancer: a case report and review of the literature.
Hoshina H; Takei H
BMC Cancer; 2019 Dec; 19(1):1217. PubMed ID: 31842789
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Aortitis Caused by Pegfilgrastim Use during Neoadjuvant Chemotherapy for Treating Breast Cancer].
Nishimura M; Morita M; Okuyama Y; Matsui C; Watanabe A; Iguchi E; Oonishi M; Yasuoka R; Sakaguchi K; Taguchi T
Gan To Kagaku Ryoho; 2022 May; 49(5):573-576. PubMed ID: 35578937
[TBL] [Abstract][Full Text] [Related]
3. Aortitis Associated with Prophylactic Short-acting Granulocyte Colony-stimulating Factor Administration: A Case Report and Review of the Literature.
Masuda Y; Oyama T; Nakazaki K; Nakai Y; Sasaki K; Matsuda K; Masamoto Y; Kurokawa M
Intern Med; 2023; 62(11):1647-1652. PubMed ID: 37258209
[TBL] [Abstract][Full Text] [Related]
4. [Two Cases of Aortitis Caused by Pegfilgrastim Administered during Chemotherapy for Breast Cancer].
Yoshimura A; Tanaka T; Nishiwada S; Kirihataya Y; Hara C; Yokotani T
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1750-1752. PubMed ID: 38303195
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte colony-stimulating factor-associated aortitis in a woman with breast cancer: a case report.
Matsumoto N; Kondo N; Wanifuchi-Endo Y; Asano T; Hisada T; Uemoto Y; Kato A; Terada M; Yamanaka N; Isogai A; Takayama M; Hasegawa T; Ito K; Mashita K; Toyama T
Surg Case Rep; 2022 Aug; 8(1):157. PubMed ID: 35980544
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Aortitis Caused by a Granulocyte-Colony-Stimulating Factor during Chemotherapy for Pancreatic Cancer].
Miyazaki K; Takadate T; Motoi F; Kamei T; Naitoh T; Unno M
Gan To Kagaku Ryoho; 2020 May; 47(5):851-853. PubMed ID: 32408335
[TBL] [Abstract][Full Text] [Related]
7. Febrile neutropenia (FN) and pegfilgrastim prophylaxis in breast cancer and non-Hodgkin's lymphoma patients receiving high (> 20%) FN-risk chemotherapy: results from a prospective observational study.
Salmon JP; Smakal M; Karanikiotis C; Wojtukiewicz MZ; Omnes Y; DeCosta L; Wetten S; O'Kelly J
Support Care Cancer; 2019 Apr; 27(4):1449-1457. PubMed ID: 30259136
[TBL] [Abstract][Full Text] [Related]
8. Single-Center Analysis of Pegfilgrastim-induced Aortitis Using a Drug Prescription Database and CT Findings.
Takamatsu A; Yoshida K; Toshima F; Kozaka K; Yamamoto N; Sai Y; Gabata T
Radiology; 2022 Dec; 305(3):729-740. PubMed ID: 35943335
[TBL] [Abstract][Full Text] [Related]
9. Migratory Aortitis Associated with Granulocyte-colony-stimulating Factor.
Shirai T; Komatsu H; Sato H; Fujii H; Ishii T; Harigae H
Intern Med; 2020 Jun; 59(12):1559-1563. PubMed ID: 32188815
[TBL] [Abstract][Full Text] [Related]
10. A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study.
Cobb PW; Moon YW; Mezei K; Láng I; Bhat G; Chawla S; Hasal SJ; Schwartzberg LS
Cancer Med; 2020 Sep; 9(17):6234-6243. PubMed ID: 32687266
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced aortitis of the subclavian artery caused by pegfilgrastim: a case report.
Jimbo H; Horimoto Y; Okazaki M; Ishizuka Y; Kido H; Saito M
Surg Case Rep; 2021 Aug; 7(1):197. PubMed ID: 34448091
[TBL] [Abstract][Full Text] [Related]
12. Pegfilgrastim-associated large-vessel vasculitis developed during adjuvant chemotherapy for breast cancer: A case report and review of the literature.
Nakamura J; Nishi TM; Yamashita S; Nakamura H; Sato K; Oda Y; Iyama A
J Oncol Pharm Pract; 2020 Oct; 26(7):1785-1790. PubMed ID: 32188319
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review.
Pfeil AM; Allcott K; Pettengell R; von Minckwitz G; Schwenkglenks M; Szabo Z
Support Care Cancer; 2015 Feb; 23(2):525-45. PubMed ID: 25284721
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte colony-stimulating factor-associated aortitis in the Japanese Adverse Drug Event Report database.
Oshima Y; Takahashi S; Tani K; Tojo A
Cytokine; 2019 Jul; 119():47-51. PubMed ID: 30875590
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review.
Mitchell S; Li X; Woods M; Garcia J; Hebard-Massey K; Barron R; Samuel M
J Oncol Pharm Pract; 2016 Oct; 22(5):702-16. PubMed ID: 26769697
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Granulocyte Colony-Stimulating Factor-Associated Aortitis during Neoadjuvant Chemotherapy for Esophageal Cancer].
Hattori S; Kano Y; Ichikawa H; Muneoka Y; Ishikawa T; Ishikawa H; Miura K; Tajima Y; Toshikawa C; Nakano M; Takizawa K; Nakano M; Shimada Y; Sakata J; Wakai T
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1817-1819. PubMed ID: 36733009
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Arteritis That Developed after Pegfilgrastim Administration during Chemotherapy for Breast Cancer].
Chino T; Oba T; Yamamoto K; Takekoshi D; Iesato A; Ito T; Kanai T; Maeno K; Ito K
Gan To Kagaku Ryoho; 2018 Dec; 45(12):1771-1774. PubMed ID: 30587739
[TBL] [Abstract][Full Text] [Related]
18. Myocarditis and carotidynia caused by Granulocyte-Colony stimulating factor administration.
Corral de la Fuente E; Barquín Garcia A; Saavedra Serrano C; Serrano Domingo JJ; Martín Huertas R; Fernández Abad M; Martínez Jáñez N
Mod Rheumatol Case Rep; 2020 Jul; 4(2):318-323. PubMed ID: 33087005
[TBL] [Abstract][Full Text] [Related]
19. A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09.
Lee KH; Kim JY; Lee MH; Han HS; Lim JH; Park KU; Park IH; Cho EK; Yoon SY; Kim JH; Choi IS; Park JH; Choi YJ; Kim HJ; Jung KH; Kim SY; Oh DY; Im SA
Support Care Cancer; 2016 Apr; 24(4):1709-17. PubMed ID: 26423618
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-associated treatment burden in breast cancer patients receiving lipegfilgrastim or pegfilgrastim: secondary efficacy data from a phase III study.
Gladkov OA; Buchner A; Bias P; Müller U; Elsässer R
Support Care Cancer; 2016 Jan; 24(1):395-400. PubMed ID: 26092233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
